Influence of deoxynivalenol on NF-κB activation and IL-8 secretion in human intestinal Caco-2 cells
Deoxynivalenol (DON) is the most prevalent trichothecene mycotoxin in crops in Europe and North America. In human intestinal Caco-2 cells, DON activates the mitogen-activated protein kinases (MAPKs). We hypothesized a link between DON ingestion and intestinal inflammation, and used Caco-2 cells to a...
Saved in:
Published in | Toxicology letters Vol. 177; no. 3; pp. 205 - 214 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Shannon
Elsevier Ireland Ltd
01.04.2008
Amsterdam Elsevier Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Deoxynivalenol (DON) is the most prevalent trichothecene mycotoxin in crops in Europe and North America. In human intestinal Caco-2 cells, DON activates the mitogen-activated protein kinases (MAPKs). We hypothesized a link between DON ingestion and intestinal inflammation, and used Caco-2 cells to assess the effects of DON, at plausible intestinal concentrations (250–10,000
ng/ml), on inflammatory mediators acting downstream the MAPKs cascade
i.e. activation of nuclear factor-κB (NF-κB) and interleukin-8 (IL-8) secretion. In addition, Caco-2 cells were co-exposed to pro-inflammatory stimuli in order to mimic an inflamed intestinal epithelium.
Dose-dependent increases in NF-κB activity and IL-8 secretion were observed, reaching 1.4- and 7.6-fold, respectively using DON at 10
μg/ml. Phosphorylation of inhibitor-κB (IκB) increased (1.6-fold) at DON levels <0.5
μg/ml. Exposure of Caco-2 cells to pro-inflammatory agents,
i.e. 25
ng/ml interleukin-1β, 100
ng/ml tumor necrosis factor-α or 10
μg/ml lipopolysaccharides, activated NF-κB and increased IL-8 secretion. Synergistic interactions between these stimuli and DON were observed.
These data show that DON induces NF-κB activation and IL-8 secretion dose-dependently in Caco-2 cells, and this effect was accentuated upon pro-inflammatory stimulation, suggesting DON exposure could cause or exacerbate intestinal inflammation. |
---|---|
ISSN: | 0378-4274 1879-3169 |
DOI: | 10.1016/j.toxlet.2008.01.018 |